Why the study?
Do very high BNP levels (>2500 ng/L) correlate with dyspnea and echocardiographic markers of heart failure in hospitalized patients?
Observational (n=67)
Do very high BNP levels (>2500 ng/L) correlate with dyspnea and echocardiographic markers of heart failure in hospitalized patients?
Effect estimate: r=0.2
p-value: p=.15
Very high BNP values (>2500 ng/L) poorly correlate with dyspnea and traditional echocardiographic markers of heart failure, questioning their clinical usefulness.
Urges caution interpreting very high BNP in hospitalized patients; leaves open its diagnostic utility pending prospective validation.
While low brain natriuretic peptide (BNP) values have been shown to improve diagnostic accuracy by excluding congestive heart failure in acute dyspnea, the meaning of excessively elevated BNP is not clear. This is a retrospective analysis of clinical, echocardiographic, and laboratory data in patients with BNP values >2500 ng/L. Sixty-seven patients (36 men) with a median age of 79 years were included. The median BNP level was 3118 ng/L (2506-5000 ng/L). Forty-six percent of the patients had no dyspnea or New York Heart Association class II dyspnea. Most patients had impaired renal function. BNP value did not correlate with ejection fraction (r=0.2; P=.15) and weakly correlated with left ventricular end-diastolic diameter index (r=0.26; P=.02). Very high BNP values only poorly correlated with dyspnea and traditional echocardiographic markers of congestive heart failure. The clinical usefulness of very high BNP values is questionable and needs evaluation in a prospective trial.
No takes yet. Share an insight, caveat, or question.
Cuculi et al. (2008) conducted an observational in Very high brain natriuretic peptide levels (n=67). Very high brain natriuretic peptide (BNP) levels (>2500 ng/L) was evaluated on Correlation with ejection fraction (r=0.2, p=.15).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: